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ABSTRACT 
In the current scenario; alcohol addiction is one of the major problems faced by the society. As a doctor it is our 
responsibility to help such alcohol addicts by counseling and treating them to recover from this addiction. It 
was with this intention that the disease Madatyaya has been chosen for the study. 
A study was conducted to access clinical efficacy of ‘Mrudvikadi Kashayam’. 20 patients of Madatyaya were 
selected in control group and 20 patients in trial group by random selection method. Control group was not 
given any medicine; however they were observed for 28 days for all parameters. Trial group patients were 
administered ‘Mrudvikadi Kashayam’ in the dose of 80ml with Jala (water) in 2 divided dose, morning and 
evening after food for the duration of 28 days. Gradation scale was used for the purpose of case taking; however 
at the time of statistical analysis Wileoxan test, Mann-Whitney test, Paired t-test, Unpaired t-test were used. It 
revealed that ‘Mrudvikadi Kashayam’ is effective in Madatyaya. It significantly reduces the symptoms Daurbalya, 
Nidranash, Aruchi, Chhardi, Hrullas, Parshwashoola, Shwasa, Murcha, Gaurava and Shirokampa. It increases the 
Haemoglobin value and lowers the LFT levels in the patients of Madatyaya.  
‘Mrudvikadi Kashayam’ is Balya, Rasayana and Pachana, and enhanced the nutritional status of such alcoholic 
patients. Also appetite and metabolism is increased due to its Deepan karma, which directly affects the Hb level 
in patients. As Pippali, Yashtimadhu, possesses Vishghna property, ‘Mrudvikadi Kashayam’ detoxified the toxic 
effects of Madya on Liver thus helpful in lowering LFT values.  
KEYWORDS: Madatyaya,  Mrudvikadi Kashayam, Ojakshaya, LFT values. 
INTRODUCTION
 The classics of Ayurveda quote the similarities 
between Madya and Visha. With its ten properties, Madya 
contradicts the ten properties of Oja and hence causes 
Madatyaya, ultimately leading to Ojakshaya. [1] 
 In Ayurved, intake of alcohol is not prohibited, but 
some rules and regulations have been laid down to reap 
the benefits and avoid the ill effects of alcohol 
consumption. 
If intaken in moderate amount, alchohol may not 
cause ill. However if continues & frequent intake causes an 
increase in the tolerance limit & thereby poses the risk of 
addiction.  
 Alcoholism is characterized by compulsive and 
uncontrolled consumption of alcohol despite its negative 
effects on the drinker's health, relationships, and social 
status. Like other drug addictions, alcoholism is very 
complicated to treat. 
Our classics too have explained a condition due to 
the excess intake of Madya, termed Madatyaya 
(Alcoholism), as a major problem faced by the society ever 
since ancient times and given the details regarding its 
types (Bheda), symptoms (Lakshana) and mode of 
treatment (Upakrama). 
In the modern sciences, the treatment for alcohol 
withdrawal is primarly in the form of pacifying the 
symptoms by tranquilizers. Ayurved has described various 
Upakramas and Kalpas of which ‘Mrudvikadi Kashayam’ 
has been elicited in the treatment of Madatyaya and 
contains ten ingredients which together act as Agni-dipana 
and Sroto-sodhana.[2] The mixture is easy to administer, 
palatable and cost-effective.  
Taking into consideration the above facts, it was 
decided to conduct this study to ascertain the effect of 
‘MrudvikadiKashayam’ in Madatyaya. On an OPD basis, 
there are very few patients available and their follow - up 
is also difficult, so clinical trials in ‘Muktangan De-addictin 
Centre’, Pune where alcoholic patients are admitted for 35 
days along with some medicines and diet regimen. As 
patients are admitted here, administering the medicine 
and observation of the patients was possible. The trial 
drug was given for 4 weeks and follow-ups were taken. 
AIM AND OBJECTIVES 
AIM 
 To study the efficacy of ‘Mrudvikadi Kashayam’ in 
Madatyaya.  
Objectives  
1) To collect the literature on Madatyaya and alcoholism 
according to Ayurvedic classics and modern science.  
2) To collect literature of ‘Mrudvikadi Kashayam’,  its 
preparation, dosage, uses etc. 
3) To assess the incidence of various types of 
Madatyaya.  
4) To record other effects, if any, during treatment.  
MATERIALS AND METHODS 
 40 patients of Madatyaya, who fulfill the inclusion 
criteria were selected from the OPD and IPD of the 
‘Muktangan’ De-addiction Centre’, Yerawada, Pune, and 
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were randomly assigned into 2 groups. Duration of the 
study was 4 weeks. Assessment was done before and after 
the study period. Selected patients were randomly 
assigned into the following two groups, each consisting of 
20 patients. 
Group A : Control Group 
20 patients were included in this group with Diet 
restriction (Pathya).  
Group B : Trial Group 
20 patients were included in this group with Diet 
restriction (Pathya). They were given the trial drug as per 
the following dosage schedule. 
Dosage schedule 
Kalpa Mrudvikadi Kashayam 
Matra 80 ml 
Sevana kala Adhobhakta (40ml each twice a day) 
Anupana Jala 
Kalavadhi For 4 weeks (28 days) 
Inclusion criteria  
 1) Patients of Madatyaya 
 2) Age group 18 years and above  
 3) Sex - Male only  
Exclusion criteria  
1) Age below 18 years (as number of patients of this 
category are negligible in the centre)  
2) Female patients (as they are not admitted in this 
particular centre)  
3) Diabetic patients (as the ingredients in Mrudvikadi 
Kashayam’ are Madhur rasatmaka)  
4) Patients with high-risk diseases E.g. severe jaundice, 
ascitis etc.  
a. Hypertensive patients of blood pressure above 
140/90 mm of Hg.  
5)  Cardiac disorders like IHD, cardiogenic shock, 
infective endocarditis etc.  
6) Severe stage of liver cirrhosis, acute hepatitis, liver 
abscess etc.  
Criteria of Assessment  
Objective Parameters 
Liver function test 
Haemogram test 
Subjective Parameters and Gradation[3-6] 
S.No. Lakshana  Gradation 
1.  Chardi 
 1 = 1 - 2 Vega 
 2 = 2 – 3 Vega 
 3 = 3 – 5 Vega 
 4 = 5 & above 
2.  Hrullas 
1 = Nausea 
2 = Nausea and excess salivation 
3 = Nausea with regurgitation 
4 = Frequently vomiting 
3.  Tandra 
1= Arati 
 2 = Jrumbha, Jadatwa 
 3 = Indriya kriyalpata 
 4 = Indriya kriyahani 
4.  Staimitya 
1= Jadyam 
 2 = Jadyam sa-ardrata 
 3 = Atijadyam sa-ardrata 
 4 = Baadhiryam 
5.  Gaurava 
 1 = Praatahkalin Gaurava 
 2 = Madhyaanha - paryant Gaurava 
 3 = Sayankal - paryant Gaurava 
 4 = Sampurna dina Gaurava 
6.  Hikka 
 1 = Occasionally 
 2 = Frequently 
 3 = Very Frequently 
 4 = Continuous 
7.  Shwasa 
 1 = Vyayamottar Shwas 
 2 = Nitya dinakarma sahit Shwas 
 3 = Aayasen Shwas 
 4 = Anayasen Shwas 
8.  Kasa 
 1 = 2 – 3 Vega/day 
 2 = 5 – 6 Vega/day 
 3 = Muhurmuhu kasa 
 4 = Satat/Ahoratra kasa 
9.  Pralapa 
 1 = Relevant talk with 5 – 10 words per minute 
 2 = Relevant talk with 10 – 15 words per minute 
 3 = Relevant talk with 15 – 20 words per minute 
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 4 = Irrelevant talk. 
10.  Shirokampa 
1 = Occasional 
2 = Frequently 
3 = Continuous but not disturbing daily routine 
4 = Continuous and disturbing daily routine 
11.  Parshvashool 
1 = Occasionally 
2 = Once or twice a day 
3 = Frequently 
4 = Continuous 
12.  Nidranasha 
 1= Kalantaren nidra for app.5-6 hrs at a Stretch 
 2 = Khandit nidra for app.2-3 hrs at a stretch and total app.4-5 hrs. 
 3 = Khandit nidra for app.3-4 hrs followed by anidra. 
 4= Anidra or nidra for 1-2 hrs. 
13.  Trishna 
1 = Ishat Trishna 
2 = Muhurmuhu Trishna 
3 = Satat Trishna – Jala sevanottar samadhan 
4 = Satat Trishna - Jala sevanottar asamadhan 
14.  Jwara 
 1 = 99-100 0F 
 2 = 101-102 0F 
 3 = 103-104 0F 
 4 = Above 104 0F 
15.  Dourbalya 
1= Dyspnoea after moderate to severe work 
2= Dyspnoea after mild to moderate work 
3= Dyspnoea after mild work 
4 = Dyspnoea at rest 
16.  Murcha 
1 = Occasionally 
2 = Frequently 
3 = Often and with short disorientation. 
4 = More often and with prolonged disorientation. 
17.  
 
Sweda 
 
1 = Kapala and Shira pradeshi swedotpatti 
2 = Kaksha and Jangha pradeshi swedotpatti 
3 = Sarwanga swedotpatti 
4 = Sarwanga swedotpatti with Sarwanga vastra ardrata 
18.  Aruchi 
 Is a Swasamvedya lakshana, which was 0 = No 
 assessed during Prashna pariksha 1=Yes 
19.  Daaha 
 Is a Swasamvedya lakshana, which was 0 = No 
 assessed during Prashna pariksha 1=Yes 
Diagnostic Criteria 
 Diagnosis was made on the basis of Lakshnas of 
Madatyaya.  
Plan of Study 
 Among the two groups, Patients of Group A were 
not given any medicine or trial drug. They were observed 
for 4 weeks, while taking weekly follow-up. During this 
period patients were given similar Ahar-Vihar as per the 
daily regimen of ‘Muktangan’. 
 Patients of Group B were given Mrudvikadi 
Kashayam’  80 ml in 2 divided dose daily i.e. in the morning 
and evening after food for 4 weeks, while following the 
above said regimen.  
Follow ups were taken on 7th, 14th, 21st and 28th day 
respectively.  
Counseling 
 Simple but regular counseling on individual, 
spouse and family level was done to all patients. Patients 
were made aware about the hazards of Madatyaya. The 
nature of disorder was explained and reassurance was 
given. The patient was helped to deal with emotional 
problems. 
Drug Review 
 As Madatyaya is a Tridosha janya Vyadhi with Agni 
dushti [7], So the Drug which is beneficial in treating both 
Agni as well as Kapha Dosha is the better choice in the 
management of Madatyaya. Mrudvikadi Kashaya is among 
those which mainly acts on Agni-dipana, Sroto-Śodhana 
and Vatapitta samaka. 
The ingredients in Mrudvikadi Kashaya [8] 
S. no Ingredient Latin Name Quantity 
1 Draksha  Vitis vinifera  1 Part 
2 Yashtimadhu Glycyrrhiza glabra 1 Part 
3 Madhuka Maduka longifolia 1 Part 
4 Pippali Piper longum 1 Part 
5 Kharjura Phoenix dactylifera 1 Part 
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6 Chandana Santalum album 1 Part 
7 Sariva Hemidesmus indicus 1 Part 
8 Musta Cyperus rotundus Linn. 1 Part 
9 Ushira Vetiveria zizanioides 1 Part 
10 Laja  Oryza sativa 1 Part 
Method: Ready prepared Mrudvikadi Kashayam was purchased from Shankar Pharmacy (G.M.P Certified) Kerala, The NOC 
and standardization certificate has been collected from the pharmacy. 
Observation and Results 
Table 1: Showing Incidence of Age 
Age Group 
Group A Group B 
No. of Pt % No. of Pt % 
20 -30yrs  3 15 2 10 
31 – 40 yrs 12 60 12 60 
41- 50 yrs 5 25 4 20 
51 – 60 yrs 0 0 2 10 
Table 2: Showing Incidence of Occupation 
Occupation 
Group A Group B 
No. of Pt % No. of Pt % 
Service 7 35 5 25 
Business 8 40 10 50 
Farmer 1 5 4 20 
Driver 4 20 1 5 
Unemployed 0 0 0 0 
Table 3: Showing Incidence of Prakruti 
Prakruti 
Group A Group B 
No. of Pt % No. of Pt % 
Vataj 5 25 7 35 
Pittaj 10 50 12 60 
Kaphaj 0 0 0 0 
Vatpittaj 4 20 3 15 
Vatkaphaj 0 0 0 0 
Kaphapittaj 1 5 0 0 
Tridoshaj 0 0 0 0 
Table 4: Showing Incidence of Type of Alcohol 
Type 
Group A Group B 
No. of Pt % No. of Pt % 
Country liquor 0 0 4 20 
Beer 2 20 2 10 
Whisky 12 60 12 60 
Rum 0 0 2 10 
Combination 2 20 0 0 
Table 5: showing Incidence of Quantity of Alcohol 
Quantity/Day (ml) 
Group A Group B 
No. of Pt % No. of Pt % 
180 – 360 1 5 3 15 
360 – 540 2 10 3 15 
540 – 720 3 15 2 10 
720 & Above 13 65 12 60 
Table 6: Showing Incidence of Frequency of Alcohol 
Frequency/day 
Group A Group B 
No. of Pt % No. of Pt % 
Once / Day 1 5 1 5 
Twice/ Day 5 25 1 5 
Thrice/ Day 2 10 5 25 
>3times / Day 12 60 13 65 
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Table 7: Showing Incidence of Duration of Alcohol Consumption 
Duration 
(Years) 
Group A Group B 
No. of Pt % No. of Pt % 
1- 5 2 10 2 10 
6 – 10  6 30 7 35 
11 – 15  8 40 9 45 
16 – 20  2 10 2 10 
Table 8: Showing Incidence of Dilution of Alcohol 
 
 
 
 
Table 9: Showing Incidence Of Food With Alcohol 
Type 
Group A Group B 
No. of Pt % No. of Pt % 
With Food 12 60 14 70 
Without Food 8 40 6 30 
Table 10: Showing Incidence of Food After Alcohol 
 
Food 
Group A Group B 
No. of Pt % No. of Pt % 
Veg 2 10 1 5 
Mixed 18 90 19 95 
Table 11: Showing Incidence of Other Habits 
Type 
Group A Group B 
No. of Pt % No. of Pt % 
Smoking 4 20 3 15 
Tobacco 6 30 5 25 
Gutakha 2 10 3 15 
Combination 6 30 7 35 
Other 2 10 2 10 
Table 12: Showing Incidence of Dosha Dushti 
Dosha 
Group A Group B 
No. of Pt % No. of Pt % 
Vata 4 20 3 15 
Pitta 10 50 12 60 
Kapha  4 20 3 15 
Tridosha 2 10 2 10 
Table 13: Showing Incidence of Sroto-Dushti 
Strotas 
Group A Group B 
No. of Pt % No. of Pt % 
Manovah 6 30 14 70 
Pranvah 3 15 8 40 
Udakvah 2 10 4 20 
Annavah 10 50 20 100 
Rasavah 9 45 17 85 
Raktavah 2 10 4 20 
Mansvah 1 5 4 20 
Medovah 3 15 9 45 
Asthivah 1 5 3 15 
Majjavah 6 30 14 70 
Shukravah 0 0 0 0 
Mutravah 4 20 10 50 
Purishvah 7 35 14 70 
Statistical Analysis 
 For calculating results from symptoms within groups before and after treatment Wilcoxon sign rank test was 
used[9]. For results in between groups, Mann-Whitney test (Equivalent to Unpaired t-test) was used. 
Type 
Group A Group B 
No. of Pt % No. of Pt % 
Diluted 14 70 15 75 
Undiluted 6 30 5 25 
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 For investigations, calculating results within groups before and after treatment Paired t-test was used and for 
results in between groups, unpaired t-test was used 
Intra Group study Control Group at Day-0 and at Day-28 
Symptom 
Median grade 
Day 0 Day 7 Day 14 Day 21 Day 28 
Chardi 2 2 1 1 0 
p-value  0.025 0.002 0.001 0.002 
Aruchi 1 0.5 0 0 0 
p-value  0.008 0.004 0.003 0.004 
Hrullas 2 2 1 1 0 
p-value  0.025 0.002 0.001 0.002 
Tantra 2 2 1 1 0 
p-value  0.025 0.002 0.001 0.002 
Gaurav 0 0 0 0 0 
p-value  1.000 0.025 0.008 0.015 
Shwas 0 0 0 0 0 
p-value  0.317 0.020 0.014 0.016 
Kasa 0 0 0 0 0 
p-value  0.317 0.317 0.317 0.317 
Shirokampa 0 0 0 0 0 
p-value  0.083 0.046 0.038 0.034 
Parshwashool 0 0 0 0 0 
p-value  0.317 0.046 0.023 0.023 
Nidranash 0 0 0 0 0 
p-value  0.083 0.005 0.005 0.004 
Trishna 0 0 0 0 0 
p-value  1.000 0.157 0.046 0.059 
Daha 0 0 0 0 0 
p-value  0.157 0.059 0.063 0.063 
Dourbalya 3 2 1.5 1 0 
p-value  0.001 0.000 0.000 0.000 
Murcha 2 1 1 0.5 0 
p-value  0.014 0.001 0.001 0.002 
Atisweda 0 0 0 0 0 
P-Value  0.317 0.317 0.317 0.317 
Intra Group Comparison 
Control Group 
1. By using Wilcoxon sign rank test p-value > 0.05 
therefore there is no significant difference between the 
day 0 and day 7 with respect to symptom Chardi, 
Aruchi, Hrullas, Parshwashool, Trishna, Daurbalya and 
Murcha. P-value < 0.05 therefore there is significant 
difference between the day 0 and day 14, day 21, day 
28with respect to symptom Chardi, Aruchi, Hrullas, 
Parshwashool, Trishna, Dourbalya and Murcha. 
2. By using Wilcoxon sign rank test p-value > 0.05 
therefore there is no significant difference between the 
day 0 and day 7, day 14, day 21, day 28 with respect to 
symptom Tandra, Gaurava, Shwas, Kasa, Shirokampa, 
Parshwashool and Atisweda. 
3. By using Wilcoxon sign rank test p-value > 0.05 
therefore there is no significant difference between the 
day 0 and day 7, day 14, day 21. P-value < 0.05 there is 
significant difference between day 0 and day 28 with 
respect to symptom Daha. 
Intra group study Trial Group at Day-0 and at Day-28 
Symptom 
Median grade 
Day 0 Day 7 Day 14 Day 21 Day 28 
Chardi 0 0 0 0 0 
p-value  0.157 0.025 0.014 0.008 
Aruchi 2 2 2 2 2 
p-value  0.157 0.046 0.025 0.014 
Hrullas 3 3 3 2 2 
p-value  0.157 0.008 0.001 0.001 
Tantra 0 0 0 0 0 
p-value  0.317 0.317 0.157 0.157 
Gaurav 0 0 0 0 0 
p-value  1.000 0.157 0.083 0.083 
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Shwas 0 0 0 0 0 
p-value  1.000 0.157 0.157 0.157 
Kasa 0 0 0 0 0 
p-value  1.000 1.000 1.000 1.000 
Shirokampa 0 0 0 0 0 
p-value  1.000 0.317 0.083 0.083 
Parshwashool 0 0 0 0 0 
p-value  0.157 0.046 0.014 0.014 
Nidranash 0 0 0 0 0 
p-value  0.180 0.180 0.102 0.102 
Trishna 0 0 0 0 0 
p-value  0.083 0.025 0.020 0.015 
Daha 0 0 0 0 0 
p-value  1.000 0.157 0.083 0.046 
Dourbalya 3 3 3 3 3 
p-value  0.157 0.014 0.003 0.002 
Murcha 2 2 2 1.5 1 
p-value  0.083 0.025 0.004 0.002 
Atisweda 0 0 0 0 0 
P-Value  1.000 1.000 0.317 0.317 
Trial Group 
1. By using Wilcoxon sign rank test p-value < 0.05 
therefore there is significant difference between the 
day 0 and day 7, day 14, day 21, day 28 with respect to 
symptom Chardi, Aruchi, Hrullas,Tandra, Daurbalya and 
Atisweda. 
2. By using Wilcoxon sign rank test p-value > 0.05 
therefore there is no significant difference between the 
day 0 and day 7 with respect to symptom Gaurav, 
Shwas, Shirokampa, Parshwashool and 10. P-value < 
0.05 therefore there is significant difference between 
the day 0 and day 14, day 21, day 28 with respect to 
symptom Gaurava, Shwas, Shirokampa, Parshwashoola 
and Nidranash. 
3. By using Wilcoxon sign rank test p-value > 0.05 
therefore there is no significant difference between the 
day 0 and day 7, day 14, day 21, day 28 with respect to 
symptom Kasa, Daha and Atisweda. 
4. By using Wilcoxon sign rank test p-value > 0.05 
therefore there is no significant difference between the 
day 0 and day 7, day 14, day 28 with respect to 
symptom Trishna. 
Inter group study 
Symptom Group 
Median grade at 
Day 0 Day 7 Day 14 Day 21 Day 28 
Chardi Trial Group 2 2 1 1 0 
 Control group 0 0 0 0 0 
 p-value 0.174 0.231 0.314 0.398 0.429 
Aruchi Trial Group 1 0.5 0 0 0 
 Control group 2 2 2 2 2 
 p-value 0.429 0.157 0.040 0.004 0.001 
Hrullas Trial Group 2 2 1 1 0 
 Control group 3 3 3 2 2 
 p-value 0.114 0.035 0.004 0.000 0.000 
Tandra Trial Group 2 2 1 1 0 
 Control group 0 0 0 0 0 
 p-value 0.040 0.052 0.096 0.121 1.000 
Gaurav Trial Group 0 0 0 0 0 
 Control group 0 0 0 0 0 
 p-value 0.738 0.738 0.904 0.841 0.383 
Shwas Trial Group 0 0 0 0 0 
 Control group 0 0 0 0 0 
 p-value 0.565 0.583 0.718 0.799 0.883 
Kasa Trial Group 0 0 0 0 0 
 Control group 0 0 0 0 0 
 p-value 0.989 1.000 0.989 0.799 0.799 
Shirokampa Trial Group 0 0 0 0 0 
 Control group 0 0 0 0 0 
 p-value 0.698 0.620 0.602 0.369 0.242 
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Parshwashool Trial Group 0 0 0 0 0 
 Control group 0 0 0 0 0 
 p-value 0.883 0.925 0.883 0.495 0.495 
Nidranasha Trial Group 0 0 0 0 0 
 Control group 0 0 0 0 0 
 p-value 0.289 0.192 0.327 0.369 0.659 
Trishna Trial Group 0 0 0 0 0 
 Control group 0 0 0 0 0 
 p-value 0.183 0.242 0.211 0.183 0.142 
Daha Trial Group 0 0 0 0 0 
 Control group 0 0 0 0 0 
 p-value 0.445 0.369 0.314 0.289 0.060 
Dourbalya Trial Group 3 2 1.5 1 0 
 Control group 3 3 3 3 3 
 p-value 0.072 0.000 0.000 0.000 0.000 
Murcha Trial Group 2 1 1 0.5 0 
 Control group 2 2 2 1.5 1 
 p-value 0.327 0.108 0.018 0.014 0.001 
Atisweda Trial Group 0 0 0 0 0 
 Control group 0 0 0 0 0 
 p-value 0.620 0.602 0.602 0.583 0.583 
Inter Group Comparison 
a. By using Mann-Whitney test[10] p-value > 0.05 therefore there is no significant difference between control group and 
study group at day 0. P-value < 0.05 therefore there is significant difference between the control group and study group at 
day 7, day 14, day 21 and day 28 with respect to symptom Hrullas and Daurbalya, Chardi, Gaurav, Shwas, Nidranash, 
Shirokampa,, Tandra, Aruchi. 
b. By using Mann-Whitney test p-value > 0.05 therefore there is no significant difference between control group and study 
group at day 0, day 14. P-value < 0.05 therefore there is significant difference between the control group and study group 
at day 7, day 14, day 21 and day 28 with respect to symptom, Murcha, Kasa, Trishna, Daha and Atisweda, Parshwashool. 
Objective parameters 
Objective 
Parameter  
Day -0  Day-28  Paired Test P Value  
 Mean score  Sd  Mean score  Sd  
Hemoglobin  Trial  13.185 1.3299 13.880 1.2833 -5.207 <0.001 HS 
Hemoglobin Control  12.755 2.4254 12.905 1.6776 -.437 0.667 NS 
Bil. Total  Trial  1.3850  .68000  .8800  .34580  4.142  <0.001HS 
Bil. Total Control  1.1765  .39055  1.0310  .30757  3.559  0.002 Sig 
Bil. Direct  Trial .4505  .18466  .299  .1135  7.230  <0.001 HS 
Bil. Direct Control .5880  .34934  .395  .1877  2.716  0.014 Sig 
Bil. Indirect  Trial .8010  .40707  .5650  .18144  3.065  0.006 Sig 
Bil. Indirect  Control .7275  .25340  .7490  .25631  .687  0.501 NS 
S.G.P.T  Trial  39.95  26.973  27.65  17.403  4.214  <0.001 HS 
S.G.P.T  Control  35.85  15.598  26.10  12.468  3.169  0.005 Sig 
S.G.O.T  Trial  33.45  21.746  20.75  14.086  6.914  <0.001 HS 
S.G.O.T  Control  33.40  14.162  24.05  11.583  3.720  0.001 Sig 
Alk. Phos  111.10  65.150  71.65  35.989  5.390  <0.001 HS  <0.001 HS 
Alk.Phos  131.25  48.444  101.55  18.492  3.237  0.004 Sig  0.004 Sig 
 By Statistical analysis of Objective parameters 
in trial group, Hemoglobin, Bilurubin total, S.G.P.T, S.G.O.T 
Alk. Phosphate shows highly significant result, in compare 
of the control group.  
DISCUSSION 
 Day by day the prevalence of alcohol related 
disorders is increasing in India may be because of effect of 
media or attraction towards the western culture. An 
increasing rate of consumption of alcohol is a major 
problem with extensive legal, social, moral, ethical 
consequences all over the world irrespective of cultural, 
geographical, educational, and economic differences. 
Indiscriminate and repeated use of alcohol produces a 
gradual, physical and moral deterioration of the individual 
and leads to crimes or perversions. This alcohol abuse 
interferes with the health, social relationships, economic 
stability which have effects further in other areas in terms 
of illness, disability, decreased productivity, accidents, 
crimes, family disorientation, economic and psychological 
hardships, and lastly death in all classes of the society. 
 Other factors like nutritional deficiency, poor 
physical health, other systemic pathologies, lack of 
emotional and family support etc increase the severity of 
the withdrawal state.[11] There is no specific treatment 
modality available in conventional science for. detoxifying 
the effects of alcohol. On the contrary, Ayurved mentions 
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many drugs for such detoxification. That is why this study 
entitled ‘A Clinical study to assess the efficacy of 
Mrudvikadi Kashayam’ in Madatyaya was carried out. The 
drug selected was Mrudvikadi Kashayam’ which is Balya, 
Rasayana, Agni deepana and Srotoshodhaka. In Madatyaya 
due to Madya along with Agni dhushti, Srotodushti is also a 
pathological change. To treat that Mrudvikadi Kashayam 
was selected.  
Age 
In this study the control group and trial group 
showed maximum 60% of patients belonging to 30 – 40 
years of age group and the prevalence goes down in 
elderly people. (Table -1) 
Occupation 
This study reveals that prevalence of Madatyaya is 
more in Business and Service category people with 40 % in 
control group and 50 % of Business in trial group, then in 
service were 35% in Trial group, 25% of control group and 
rest were drivers and others including retired and 
unemployed etc. This may be because of stress of business 
and office, friends company and financial soundness. 
(Table - 2) 
Prakruti 
 In control (50%) as well as in trial group (60%) 
maximum patients were of Pittaj Prakruti. The patients of 
Vataj Prakruti occupy second place having 25% in Control 
and 35% in Trial group. (Table - 3)  
Type of Alcohol 
 This study shown maximum people of control 
group were addicted to Whisky (60 %) but in Trial group 
people taking Beer and combination of more than one type 
occurred more (60%). This may be because of cost, the 
Whisky being cheaper and produces maximum kick hence 
maximum people use it and local beverages are still in use 
in spite of ban over it. (Table - 4) 
Quantity of Alcohol consumption 
  This study showed maximum people of control 
(65%) and trial group (60%) takes 720ml & more alcohol 
per day. (Table - 5) 
Frequency of Alcohol consumption 
  0% peoples of control and 65% of trial group 
consumes alcohol more than 3 times per day (Table-6) 
Duration of Alcohol Consumption 
  40% of people in control group and 45% of 
peoples in trial group consuming alcohol since 11-15 
years. Peoples consuming alcohol since 6-10 years are 
30% in control group and 35% in trial group whereas 
peoples consuming alcohol above 16 years are 10% in 
both the groups. (Table - 7) 
Dilution of Alcohol Consumption 
  This study reveals that 70% people of control and 
75 % of trial group consumes alcohol in diluted form 
(Table-8) 
  For dilution they may prefer soda, carbonated 
cold drinks or only water.  
Food intake with Alcohol consumption 
60% people of control group and 70% of trial group 
consumes alcohol with food. (Table -9) 
Food intake after Alcohol consumption 
  This study shows that maximum no. of people i.e. 
90% in control group and 95% in trial group take mixed 
type of food after consumption of alcohol. Thus 
aggravating the Dosha & Dushti. (Table -10) 
Other Addiction 
 30% Of peoples in control and 25% in trial group 
have a habit of tobacco chewing. But large number of 
patients i.e. 30% in control group and 35% in trial group 
have habit of either 2 or more than 2 of the following 
addictions i.e. Gutakha, smoking and tobacco called 
combination type of habit. These addictions are indicative 
of Rajoguna vridhi of Mana. (Table-11) 
Dosha Dushti 
  This study reveals that in majority of people(60%) 
Pitta get affected largely, whereas Vata and Kapha Dosha 
were found to be vitiated to a lesser extent. (Table - 12) 
Sroto-Dushti 
  According to this study, Annavaha and Rasavaha 
srotas get largely affected in alcoholics of both groups but 
it also reveals that Manovaha, Majjavaha and Purishvaha 
srotasa are the next mostly affected Srotasa. (Table – 13)  
I. Effect on Symptoms  
  ‘Mrudvikadi Kashayam’ gives relief in the 
subjective symptoms as well as in objective criteria like 
Liver Function test of patients of Madatyaya. The result of 
this study showed there was significant improvement in 
the trial group compared to control group. 
A. Effect in Control Group  
In control group, up to some extent, there is significant 
reduction in the severity of Chardi, Hrullasa and Aruchi at 
day 28. This can be due to- 
1) Complete abstinence of alcohol intake i.e.  
 Nidanparivarjan. 
2) Balanced diet/regimen is followed. 
3) Supplemented by yoga, meditation and counselling.  
A) Effect in Trial Group 
  In the trial group out of 15 symptoms one 
symptom showed highly significant relief, 8 symptoms 
shows significant relief and 6 symptoms shows no 
significant reduction in the severity. 
1. Daurbalya [H.S] 
  In control group at Day-0, 70% of patients were of 
Grade-3 which was reduced by Day 28 in 60% patients. 
However in the trial group 40% patients of Grade 3 
showed a reduction of 100% by the day 21. This indicates 
that the medication alleviated the same severity of the aim 
within a lesser time period i.e. 1 week early. 
 This can be due to the Rasayan karma of Draksha 
by causing Dhatvagnideepana due to its Madhur rasa and 
Sheeta veerya and by expelling Dosha accumulated in 
Srotasa. The Balya, Brumhan actions of also helps to 
reduce Daurbalya. 
2 Hrullasa-[S] 
  In the Hrullasa Lakshana of the control group 
maximum number of patients were in grade 3 (50%) that 
was reduced in 25% of patients by Day- 28. However in the 
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trial group 75% patients showed grade 3 severities and 
that was altered to grade 1 by the day 21th in 100% 
patients. This indicates that the medicine alleviated the 
same severity of the Lakshana within a lesser time period. 
To relieve the Hrullasa, ingredient like Musta, 
Pippali, Ushira in ‘Mrudvikadi Kashayam’ having Pittaghna 
property may have proved useful. 
3 Chhardi [S] 
  In control group at Day-0, 30% of patients were of 
Grade-4 which was decreased to 20 % by Day 28 in 30% 
patients. However in the trial group 60% patients of Grade 
3 showed a reduction of 75% by the day 21. This indicates 
that the medication alleviated the greater severity of the 
Lakshana within a lesser time period (3 weeks early).  
This is due to the Deepan Pachan & Vatanuloman action of‘ 
Mrudvikadi Kashayam’. 
4 Gaurav [S] 
  Considering the Gaurav Lakshana, In control 
group at Day-0, 30% of patients were of Grade-2 which 
was reduced within Day 28 in 10% patients. However in 
the trial group 25% patients of Grade 2 showed a 
reduction of 100% by the day 21. 
  This indicates that the medicine reduced the 
severity of Gaurav within a lesser time period. In case of 
Gaurava, Kaphaghna and Kledaghna guna of drug like 
Pippali, Musta are responsible.  
5 Shwasa [S] 
  In control group at Day-0, 30% of patients were of 
Grade-1 which was reduced by Day 21 in 100% patients. 
However in the trial group 20% patients of Grade 2 
showed a reduction of 100% by the day 28. This indicates 
that the medication alleviated the greater severity of the 
Lakshana.  
6 Nidranash [s] 
  In the control group 50% patients showed Grade-
3 severity that was reduced by Day-28 in 20%. 
However, in the Trial group 35% patients of Grade 3 
showed a relief of 100% by the day 14. In Nidranash the 
same severity of the Lakshna was achieved within a lesser 
time period i.e. 2 weeks early  
7 Aruchi [.S.] 
  Considering the Aruchi Lakshana, of the control 
group 30% of patients showed reduction in symptom up to 
25% by 28th day. However in the trial group 50% patients 
showed relief of 75% in the symptom by the 28th day. 
  This indicates that the medication alleviated a 
greater severity of the lakshana which may be due to 
Deepana guna of ‘Mrudvikadi Kashayam’. 
8  Shirokampa [S] 
  In control group at Day-0, 20% of patients were of 
Grade-2 which was reduced by Day 28 in 10% patients. 
However in the trial group 20% patients of Grade 2 
showed a reduction of 100% by the day 28.This indicates 
that the medication reduced the same severity of the 
Lakshana within a lesser time period (1 week early). 
9 Tandra 
 In control group at Day-0, 20% of patients were of 
Grade-2 which was reduced by Day 28 in 10% patients. 
However in the trial group 30% patients of Grade 2 
showed a reduction of 100% by the day 28. This indicates 
that the medication reduced the same severity of the 
Lakshana within a lesser time period 
II. Changes in Pathological Tests 
Considering the Pathological investigations we 
conducted Haemoglobin and Liver Function Tests which 
includes Total Bilirubin, Direct Bilirubin, Indirect Bilirubin, 
SGPT, SGOT, and Serum Alkaline Phosphatase. 
A) Effect in control group 
Among the above said investigations in Control 
Group,- there were no significant changes in all the tests 
except SGPT.  
B) Effect in trial group 
There is highly significant reduction in all the 
investigations except Bilirubin Indirect. 
1) Effect on Hemoglobin percentage  
Before the treatment with ‘Mrudvikadi Kashayam’, 
mean value of Haemoglobin was 13.18 which became 
13.88 after the treatment, showing increase of.70 in mean 
value whereas in control group mean difference was 0.15 
only. It shows drug was effective and statistically highly 
significant. 
This could be possible due to the ingredients in 
‘Mrudvikadi Kashayam’ especially Draksha, Yashtimadhu, 
Pippali which are having Rakta prasadana and Balya 
properties, Raktavardhaka, Yakriduttejaka, Pleeha-
vriddhihara, Rasayana, 
Also appetite and metabolism could have been 
increased due to Deepan karma of ‘Mrudvikadi Kashayam’, 
which directly affects the Hb level in trial group. Most of 
the ingredients of Mrudvikadi kasaya are Madhur 
Rasatamaka, Sheeta Viryatamaka, Vata Pittashamaka and 
Shonitsthapaka it could be helpful in increasing 
Haemoglobin. 
1) Liver Function Test 
Likewise in LFT it showed that the drug was 
effective and statistically highly significant in the 
investigations of Total Bilirubin, Direct Bilirubin, SGPT, 
SGOT and Alkaline Phosphate. 
1) Total Bilirubin 
After the treatment with ‘Mrudvikadi Kashayam’, 
mean difference of Total Bilirubin (mg/dl) was decreased 
by 1.03 whereas in control group decrease in mean 
difference was 0.86 only. It implies that drug was 
effective and statistically highly significant.  
2) Direct Bilirubin  
After the treatment, mean difference of Direct 
Bilirubin (mg/dl) was decreased by 0.8 however in 
control group was 0.16 only. It shows drug was effective 
and statistically highly significant. 
3) SGPT 
 After the treatment, mean difference of SGOT 
(IU/L) was decreased by 12 however in control group 
decrease in mean difference were 9.75 only. It clearly 
shows drug was effective and statistically highly 
significant. 
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5) SGOT 
After the treatment, mean value of SGOT (IU/L) 
was decreased by 13 on the other hand in control group 
mean difference was decreased by 9 It shows drug was 
effective and statistically highly significant. 
6) Alkaline Phosphate 
After the treatment with ‘Mrudvikadi Kashayam’, 
average difference of Alkaline Phosphate (IU/L) was 
decreased by 39. whereas in control group decrease in 
difference was 30 only. It implies that drug was effective 
and statistically highly significant. 
As Chandan, Yashtimadhu, possesses Vishghna[12] 
property; ‘Mrudvikadi Kashayam’ could probably de-toxify 
the toxic effects of Madya on Liver thus helpful in lowering 
LFT values.  
Probable Action of ‘Mrudvikadi kashayam’  
 Considering the each ingredient of formulation the 
probable attributes and action of ‘Mrudvikadi Kashayam’ 
could be as follows. 
Veerya- Sheeta 
Vipak- Madhur 
Rasa- Madhura,Kashay 
Guna-  Guru, Snigdha. 
Doshghnata- Vatpittaghna. 
Karma- Agnideepana Ojovardhak, Vishaghna Balya, 
Bruhan, Medhya. 
Rogaghnata: Raktavardhaka, Yakriduttejaka, Pleeha-
vriddhihara, Rasayana, Balya. 
Daurbalya 
1. Being Vatpittashamaka it reduces the Vatpittaprakopa in 
Madatyaya. 
2. By Agnideepan karma it helps to corrects the Annavaha 
srotodushti & further the Rasavaha srotas. 
3. Antitoxic property minimizes the toxic effects in the 
body produced due to excess intake of Alcohol.  
4. Ojovardhak property corrects the Ojavikruti. 
5. The general weakness in Madatyaya is reduced due to 
Bruhan, Balya karma of ‘Mrudvikadi Kashayam’. 
This probable action may be due to the cumulative effect of 
the formulation as a whole. 
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